Expression of miR-1180 in non-small cell lung cancer and its clinical significance

KONG Lingyu; ZHU Tianyi

doi:10.7619/jcmp.20213761

Journal of Clinical Medicine in Practice > 2022 > 26(3): 76-80. > DOI: 10.7619/jcmp.20213761

KONG Lingyu, ZHU Tianyi. Expression of miR-1180 in non-small cell lung cancer and its clinical significance[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 76-80. DOI: 10.7619/jcmp.20213761

Citation:

PDF (928 KB)

Expression of miR-1180 in non-small cell lung cancer and its clinical significance

Department of Respiratory Medicine, General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shenyang, Liaoning, 110000

More Information

Received Date: September 16, 2021
Available Online: March 10, 2022
Published Date: February 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To investigate the expression of miR-1180 in serum and tissues of non-small cell lung cancer (NSCLC), and to analyze its relationship with clinicopathological characteristics and its value for disease diagnosis and prognostic evaluation.
Methods Seventy-two patients with NSCLC and 50 patients with benign lung disease who received treatment at the same period were selected as the study subjects. Fasting venous blood of NSCLC patients and those with benign lung diseases was collected, and the cancer tissues and adjacent tissues were collected from NSCLC patients. Quantitative real-time polymerase chain reaction(qRT-PCR)was used to detect the relative expression of miR-1180 in serum and tissues. All patients with NSCLC were followed up for 5 years, and their survival status was counted.
Results The relative expression levels of miR-1180 in serum of the NSCLC patients were significantly higher than those in patients with the benign lung diseases (P < 0.05); the relative expression of miR-1180 in the cancer tissues was significantly higher than that in the adjacent tissues (P < 0.05). The relative expression of miR-1180 in serum and tissues of NSCLC patients was not correlated with gender, age, smoking history and pathological type (P > 0.05), but was related to tumor size, TNM stage, lymph node metastasis and degree of differentiation (P < 0.05). Serum miR-1180 had a high value in the auxiliary diagnosis of NSCLC, the area under the curve (AUC) was 0.747, the 95%CI was 0.580~0.914, and the accuracy was 0.754. The 5-year survival rate of patients with miR-1180 high expression was significantly lower than that of patients with low expression of miR-1180 (P < 0.05).
Conclusion MiR-1180 is abnormally highly expressed in serum and cancer tissues of NSCLC, and its expression level is closely related to the malignant progression of tumors. MiR-1180 can be used as a new biomarker for diagnosis and prognostic evaluation of NSCLC.
- non-small cell lung cancer,
- miR-1180,
- diagnosis,
- prognosis,
- biomarkers,
- survival rate

FullText(HTML)

References (19)

References

[1]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[2]	DING N, ZHOU N, LI Q L, et al. Analysis of middle-and long-term efficacy of thoracoscope-assisted segmental resection of the lung on non-small cell lung cancer in the early stage[J]. Oncol Lett, 2018, 15(3): 3662-3668.
[3]	BICA-POP C, COJOCNEANU-PETRIC R, MAGDO L, et al. Overview upon miR-21 in lung cancer: focus on NSCLC[J]. Cell Mol Life Sci, 2018, 75(19): 3539-3551. doi: 10.1007/s00018-018-2877-x
[4]	KANG M, LI Y, ZHAO Y, et al. miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer[J]. Clin Transl Oncol, 2018, 20(4): 457-466. doi: 10.1007/s12094-017-1730-2
[5]	ZHU D Y, GAO W X, ZHANG Z M. microRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-κB signaling pathway activation[J]. Oncol Lett, 2018, 15(4): 4775-4780.
[6]	余斌, 丁佑铭, 廖晓锋. 基于生物信息学的肝细胞癌组织miR-1180表达与临床意义分析[J]. 中国普通外科杂志, 2018, 27(7): 862-869.
[7]	陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201501001.htm
[8]	孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901001.htm
[9]	陈秀红, 李坤, 靳爽, 等. 非小细胞肺癌中卵巢肿瘤泛素异肽酶1与程序性死亡受体-1配体的表达相关性[J]. 实用临床医药杂志, 2021, 25(23): 31-36. doi: 10.7619/jcmp.20213152
[10]	DETTERBECK F C, BOFFA D J, KIM A W, et al. The eighth edition lung cancer stage classification[J]. Chest, 2017, 151(1): 193-203. doi: 10.1016/j.chest.2016.10.010
[11]	李思佳, 宋新宇, 李文新. 肺癌干细胞的研究进展[J]. 巴楚医学, 2020, 3(1): 100-103, 111. https://www.cnki.com.cn/Article/CJFDTOTAL-BMJJ202001024.htm
[12]	中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2018版)[J]. 肿瘤研究与临床, 2018, 30(12): 793-824. doi: 10.3760/cma.j.issn.1006-9801.2018.12.001
[13]	CHU G C W, LAZARE K, SULLIVAN F. Serum and blood based biomarkers for lung cancer screening: a systematic review[J]. BMC Cancer, 2018, 18(1): 181. doi: 10.1186/s12885-018-4024-3
[14]	黄成军, 关菁, 覃丽华. 微小RNA-1180对肝癌细胞侵袭迁移和TGF-β信号通路的影响[J]. 临床肿瘤学杂志, 2019, 24(11): 989-993. doi: 10.3969/j.issn.1009-0460.2019.11.006
[15]	GU L, ZHANG J Q, SHI M M, et al. The effects of miRNA-1180 on suppression of pancreatic cancer[J]. Am J Transl Res, 2017, 9(6): 2798-2806.
[16]	GU Z W, HE Y F, WANG W J, et al. miR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway[J]. J Zhejiang Univ Sci B, 2019, 20(3): 219-237. doi: 10.1631/jzus.B1800190
[17]	GE Q Q, WANG C H, CHEN Z, et al. The suppressive effects of miR-1180-5p on the proliferation and tumorigenicity of bladder cancer cells[J]. Histol Histopathol, 2017, 32(1): 77-86.
[18]	CHEN E G, ZHANG J S, XU S, et al. Long non-coding RNA DGCR5 is involved in the regulation of proliferation, migration and invasion of lung cancer by targeting miR-1180[J]. Am J Cancer Res, 2017, 7(7): 1463-1475.
[19]	CHEN M B, HUANG X M, LI L, et al. A regulatory axis of circ_0008193/miR-1180-3p/TRIM62 suppresses proliferation, migration, invasion, and Warburg effect in lung adenocarcinoma cells under hypoxia[J]. Med Sci Monit, 2020, 26: e922900.

Cited By

Cited by

Periodical cited type(6)

1.	秦勤，李刚，赵磊，孙杰，伍万里，杜书迪. 不同时机小骨窗手术治疗高血压脑出血的效果及预后对比. 中国综合临床. 2025(01): 44-49 .
2.	李海龙，李冬华，李密，张喜兵，胡泽红，曹先志. 不同入路下行血肿清除术治疗基底节高血压性脑出血的临床疗效比较. 中国临床医生杂志. 2024(09): 1055-1058 .
3.	李俊明，王乃冰. 经侧裂-岛叶入路显微手术治疗基底节区高血压脑出血的效果及对神经功能、血管活性因子的影响. 临床医学研究与实践. 2024(34): 71-74 .
4.	董玉，王语嫣. 乌拉地尔注射液联合神经节苷脂对高血压基底节区脑出血开颅患者预后的影响. 中国医师杂志. 2024(11): 1704-1707 .
5.	伍万里，李刚，孙杰，赵磊，秦勤. 不同时期小骨窗显微手术治疗基底节高血压脑出血的效果. 中外医学研究. 2023(15): 10-13 .
6.	李锦晓，项朝晖，晁先礼，王峰波，袁小瓦. 神经内镜与显微手术治疗高血压基底节区脑出血的临床比较. 中外医疗. 2023(22): 90-93 .

Other cited types(0)

Get Citation

PDF

XML

Article views (241) PDF downloads (12) Cited by(6)

Turn off MathJax

Article Contents

Abstract

References

Expression of miR-1180 in non-small cell lung cancer and its clinical significance

Abstract

References

Cited by

Periodical cited type(6)

Other cited types(0)

Catalog

Export File

Citation

Format

Content